Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
2.6 USD
-0.38%
Market Closed
Updated:
Apr 29, 2024
Adaptive Biotechnologies Corp
Operating Expenses
|
Adaptive Biotechnologies Corp
Operating Expenses Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Operating Expenses
-$296.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Expenses
-$9.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Expenses
-$16.1B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Expenses
-$1.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Expenses
-$2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Expenses
-$3.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-14%
|
See Also
What is Adaptive Biotechnologies Corp's Operating Expenses?
Operating Expenses
-296.3m
USD
-296.3m
USD
Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Operating Expenses amounts to -296.3m USD.
What is Adaptive Biotechnologies Corp's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-28%
-28%
Over the last year, the Operating Expenses growth was 9%. The average annual Operating Expenses growth rates for Adaptive Biotechnologies Corp have been -9% over the past three years , -28% over the past five years .
You don't have any saved screeners yet
